omeprazole and celecoxib

omeprazole has been researched along with celecoxib in 38 studies

Research

Studies (38)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's21 (55.26)29.6817
2010's17 (44.74)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Artursson, P; Bergström, CA; Hoogstraate, J; Matsson, P; Norinder, U; Pedersen, JM1
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A1
Artursson, P; Haglund, U; Karlgren, M; Kimoto, E; Lai, Y; Norinder, U; Vildhede, A; Wisniewski, JR1
Dalvie, D; Loi, CM; Smith, DA1
Davis, MI; Khan, J; Li, SQ; Patel, PR; Shen, M; Sun, H; Thomas, CJ1
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Alarcón de la Lastra, C; Berenguer, B; Martín, MJ; Moreno, FJ1
Daspet, MK; Gscheidel, D; Le Coz, CJ; Lipsker, D1
Chan, FK; Chung, SC; Hui, AJ; Hung, LC; Lee, KC; Leung, VK; Leung, WK; Suen, BY; Sung, JJ; To, KF; Wong, VW; Wu, JC1
Graham, DY1
Dahl, ML; Eliasson, E; Griskevicius, L; Hassan, M; Hidestrand, M; Sandberg, M; Tybring, G; Yasar, U1
Lanas, A1
Lems, WF; Nurmohamed, MT1
Chan, FK; Ho, JT; Lau, WH; Lee, KK; Lee, VW; Suen, BY; Sung, JY; You, JH; Yung, MY1
Oviedo, JA; Wolfe, MM1
Chan, FK; Chung, SC; Hui, AJ; Hung, LC; Lee, YT; Leung, WK; Suen, BY; Sung, JJ; To, KF; Wong, VW; Wu, JC1
Cryer, B1
Eisen, GM; Fort, JG; Goldstein, JL; Gralnek, IM; Lewis, B; Zlotnick, S1
Chiou, CF; Ofman, JJ; Spiegel, BM1
Gautam, P; Poonam, D; Vinay, CS1
Scheiman, JM1
Chan, AO; Chu, KM; Hu, WH; Hui, WM; Lai, KC; Lam, SK; Wong, BC; Wong, J; Wong, WM1
Aisenberg, J; Berger, MF; Bhadra, P; Eisen, GM; Goldstein, JL; Gralnek, IM; Lewis, B1
Berger, M; Chan, FK; Niculescu, L; Peura, D; Wilcox, CM1
Andersson, M; Arvidsson, A; Brevinge, H; Lagerstedt, K; Lönnroth, C; Lundholm, K; Nordgren, S1
Bernatsky, S; Rahme, E1
Berger, MF; Chan, FK; Goldstein, JL; Lanas, A; Nguyen, H; Scheiman, J1
Jobe, BA; Lombard, CM; Triadafilopoulos, G1
Bercik, P; Bolla, M; Collins, SM; de Palma, G; Denou, E; Jury, J; McKnight, W; Ongini, E; Syer, S; Verdu, E; Vong, L; Wallace, JL1
Feng, GS; Lam, S; Li, J; Li, JY; Liu, WD; Lu, AP; Ma, JL; Pan, KF; Shen, L; Wong, BC; Xia, HH; You, WC; Zhang, L; Zhang, XD1
Blackler, R; Bolla, M; Ongini, E; Syer, S; Wallace, JL1
Chan, FK; Goldstein, JL; Lanas, A; Li, C; Peura, DA; Sands, GH; Scheiman, JM; Wilcox, CM1
Essex, MN; Kellner, HL; Li, C1
Fukazawa, H; Inoue, M; Kaneko, Y; Miyazaki, Y; Niki, M; Ohno, H; Tanabe, K; Umeyama, T; Urai, M1
Buttgereit, F; Spies, CM; Stemmler, E1
Li, JY; Ma, JL; Pan, KF; Shen, L; You, WC; Zhang, L; Zhang, Y; Zhou, T1

Reviews

3 review(s) available for omeprazole and celecoxib

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016
Gastroprotection by coxibs: what do the Celecoxib Long-Term Arthritis Safety Study and the Vioxx Gastrointestinal Outcomes Research Trial tell us?
    Rheumatic diseases clinics of North America, 2003, Volume: 29, Issue:4

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Celecoxib; Cyclooxygenase Inhibitors; Diclofenac; Enzyme Inhibitors; Gastrointestinal Hemorrhage; Humans; Lactones; Misoprostol; Omeprazole; Osteoarthritis; Proton Pump Inhibitors; Pyrazoles; Randomized Controlled Trials as Topic; Sulfonamides; Sulfones

2003
Minimizing complications from nonsteroidal antiinflammatory drugs: cost-effectiveness of competing strategies in varying risk groups.
    Arthritis and rheumatism, 2005, Apr-15, Volume: 53, Issue:2

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Inflammatory Agents, Non-Steroidal; Arthritis; Aspirin; Celecoxib; Cost-Benefit Analysis; Drug Therapy, Combination; Gastrointestinal Diseases; Humans; Lactones; Lansoprazole; Naproxen; Omeprazole; Proton Pump Inhibitors; Pyrazoles; Rheumatology; Sulfonamides; Sulfones

2005

Trials

13 trial(s) available for omeprazole and celecoxib

ArticleYear
Celecoxib versus diclofenac and omeprazole in reducing the risk of recurrent ulcer bleeding in patients with arthritis.
    The New England journal of medicine, 2002, Dec-26, Volume: 347, Issue:26

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Arthritis; Celecoxib; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Diclofenac; Double-Blind Method; Drug Therapy, Combination; Duodenal Ulcer; Helicobacter pylori; Humans; Isoenzymes; Membrane Proteins; Omeprazole; Peptic Ulcer Hemorrhage; Probability; Prospective Studies; Prostaglandin-Endoperoxide Synthases; Pyrazoles; Risk Factors; Secondary Prevention; Stomach Ulcer; Sulfonamides

2002
Economic analysis of celecoxib versus diclofenac plus omeprazole for the treatment of arthritis in patients at risk of ulcer disease.
    Alimentary pharmacology & therapeutics, 2003, Jul-15, Volume: 18, Issue:2

    Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Arthritis, Rheumatoid; Celecoxib; Cost-Benefit Analysis; Delayed-Action Preparations; Drug Therapy, Combination; Female; Humans; Male; Omeprazole; Peptic Ulcer Hemorrhage; Pyrazoles; Risk Factors; Sulfonamides

2003
Celecoxib versus diclofenac plus omeprazole in high-risk arthritis patients: results of a randomized double-blind trial.
    Gastroenterology, 2004, Volume: 127, Issue:4

    Topics: Adult; Aged; Arthritis; Celecoxib; Diclofenac; Double-Blind Method; Drug Therapy, Combination; Dyspepsia; Female; Humans; Male; Middle Aged; Omeprazole; Peptic Ulcer; Prospective Studies; Pyrazoles; Recurrence; Sulfonamides

2004
Video capsule endoscopy to prospectively assess small bowel injury with celecoxib, naproxen plus omeprazole, and placebo.
    Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, 2005, Volume: 3, Issue:2

    Topics: Adolescent; Adult; Aged; Celecoxib; Cyclooxygenase Inhibitors; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Endoscopy, Gastrointestinal; Female; Follow-Up Studies; Humans; Intestinal Mucosa; Intestine, Small; Male; Middle Aged; Naproxen; Omeprazole; Probability; Prospective Studies; Pyrazoles; Reference Values; Risk Assessment; Severity of Illness Index; Statistics, Nonparametric; Sulfonamides; Video Recording

2005
What are the effects of cyclooxygenase-2-specific inhibitors on the small bowel?
    Nature clinical practice. Gastroenterology & hepatology, 2005, Volume: 2, Issue:5

    Topics: Adult; Celecoxib; Cyclooxygenase Inhibitors; Double-Blind Method; Drug Therapy, Combination; Follow-Up Studies; Humans; Intestinal Diseases; Intestinal Mucosa; Intestine, Small; Naproxen; Omeprazole; Prospective Studies; Pyrazoles; Sulfonamides

2005
Celecoxib compared with lansoprazole and naproxen to prevent gastrointestinal ulcer complications.
    The American journal of medicine, 2005, Volume: 118, Issue:11

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Celecoxib; Cyclooxygenase 2 Inhibitors; Drug Therapy, Combination; Dyspepsia; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Incidence; Lansoprazole; Male; Middle Aged; Naproxen; Omeprazole; Peptic Ulcer; Peptic Ulcer Hemorrhage; Prospective Studies; Proton Pump Inhibitors; Pyrazoles; Recurrence; Risk Factors; Sulfonamides; Treatment Outcome

2005
Small bowel mucosal injury is reduced in healthy subjects treated with celecoxib compared with ibuprofen plus omeprazole, as assessed by video capsule endoscopy.
    Alimentary pharmacology & therapeutics, 2007, May-15, Volume: 25, Issue:10

    Topics: Adolescent; Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Capsule Endoscopy; Celecoxib; Drug Therapy, Combination; Female; Humans; Ibuprofen; Intestinal Diseases; Intestinal Mucosa; Male; Middle Aged; Omeprazole; Pyrazoles; Sulfonamides

2007
Preoperative treatment with a non-steroidal anti-inflammatory drug (NSAID) increases tumor tissue infiltration of seemingly activated immune cells in colorectal cancer.
    Cancer immunity, 2008, Feb-29, Volume: 8

    Topics: Adenocarcinoma; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Celecoxib; Cell Movement; Colorectal Neoplasms; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Dendritic Cells; Female; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; HLA-D Antigens; Humans; Indomethacin; Lymphocyte Subsets; Lymphocytes, Tumor-Infiltrating; Macrophages; Male; Middle Aged; Neoplasm Proteins; Omeprazole; Premedication; Preoperative Care; Pyrazoles; Sulfonamides

2008
Celecoxib versus omeprazole and diclofenac in patients with osteoarthritis and rheumatoid arthritis (CONDOR): a randomised trial.
    Lancet (London, England), 2010, Jul-17, Volume: 376, Issue:9736

    Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Arthritis, Rheumatoid; Celecoxib; Cyclooxygenase 2 Inhibitors; Diclofenac; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Lower Gastrointestinal Tract; Male; Middle Aged; Omeprazole; Osteoarthritis; Peptic Ulcer; Pyrazoles; Research Design; Risk Assessment; Risk Factors; Sulfonamides; Treatment Outcome; Upper Gastrointestinal Tract

2010
Effects of selective COX-2 inhibitor and Helicobacter pylori eradication on precancerous gastric lesions.
    Gut, 2012, Volume: 61, Issue:6

    Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Celecoxib; Clarithromycin; Cyclooxygenase 2 Inhibitors; Double-Blind Method; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Precancerous Conditions; Pyrazoles; Stomach; Stomach Neoplasms; Sulfonamides

2012
Risk factors associated with a decrease ≥2 g/dL in haemoglobin and/or ≥10% haematocrit in osteoarthritis patients taking celecoxib or a nonselective NSAID plus a PPI in a large randomised controlled trial (CONDOR).
    Alimentary pharmacology & therapeutics, 2012, Volume: 36, Issue:5

    Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Celecoxib; Cyclooxygenase 2 Inhibitors; Diclofenac; Double-Blind Method; Female; Hematocrit; Hemoglobins; Humans; Male; Middle Aged; Omeprazole; Osteoarthritis; Proton Pump Inhibitors; Pyrazoles; Risk Factors; Sulfonamides

2012
Efficacy and safety of celecoxib versus diclofenac and omeprazole in elderly arthritis patients: a subgroup analysis of the CONDOR trial.
    Current medical research and opinion, 2012, Volume: 28, Issue:9

    Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Arthritis; Celecoxib; Cyclooxygenase 2 Inhibitors; Diclofenac; Double-Blind Method; Humans; Omeprazole; Prospective Studies; Pyrazoles; Sulfonamides

2012
Helicobacter pylori, cyclooxygenase-2 and evolution of gastric lesions: results from an intervention trial in China.
    Carcinogenesis, 2015, Volume: 36, Issue:12

    Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Celecoxib; China; Clarithromycin; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Dinoprostone; Double-Blind Method; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Precancerous Conditions; Stomach; Stomach Neoplasms

2015

Other Studies

22 other study(ies) available for omeprazole and celecoxib

ArticleYear
Prediction and identification of drug interactions with the human ATP-binding cassette transporter multidrug-resistance associated protein 2 (MRP2; ABCC2).
    Journal of medicinal chemistry, 2008, Jun-12, Volume: 51, Issue:11

    Topics: Administration, Oral; Animals; Antineoplastic Agents; Antipsychotic Agents; Antiviral Agents; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Biological Transport; Cell Line; Computer Simulation; Cytochrome P-450 Enzyme System; Drug-Related Side Effects and Adverse Reactions; Estradiol; Humans; Insecta; Liver; Models, Molecular; Multidrug Resistance-Associated Protein 2; Multidrug Resistance-Associated Proteins; Neoplasm Proteins; Pharmaceutical Preparations; Pharmacology; Structure-Activity Relationship

2008
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
    Chemical research in toxicology, 2010, Volume: 23, Issue:1

    Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship

2010
Classification of inhibitors of hepatic organic anion transporting polypeptides (OATPs): influence of protein expression on drug-drug interactions.
    Journal of medicinal chemistry, 2012, May-24, Volume: 55, Issue:10

    Topics: Atorvastatin; Biological Transport; Drug Interactions; Estradiol; Estrone; HEK293 Cells; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; In Vitro Techniques; Least-Squares Analysis; Liver; Liver-Specific Organic Anion Transporter 1; Models, Molecular; Multivariate Analysis; Organic Anion Transporters; Organic Anion Transporters, Sodium-Independent; Protein Isoforms; Pyrroles; Solute Carrier Organic Anion Transporter Family Member 1B3; Structure-Activity Relationship; Transfection

2012
Which metabolites circulate?
    Drug metabolism and disposition: the biological fate of chemicals, 2013, Volume: 41, Issue:5

    Topics: Humans; Metabolic Clearance Rate; Pharmaceutical Preparations

2013
Identification of potent Yes1 kinase inhibitors using a library screening approach.
    Bioorganic & medicinal chemistry letters, 2013, Aug-01, Volume: 23, Issue:15

    Topics: Binding Sites; Cell Line; Cell Survival; Drug Design; Humans; Hydrogen Bonding; Molecular Docking Simulation; Protein Kinase Inhibitors; Protein Structure, Tertiary; Proto-Oncogene Proteins c-yes; Small Molecule Libraries; Structure-Activity Relationship

2013
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
    Toxicological sciences : an official journal of the Society of Toxicology, 2013, Volume: 136, Issue:1

    Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests

2013
Chronic gastric ulcer healing in rats subjected to selective and non-selective cyclooxygenase-2 inhibitors.
    European journal of pharmacology, 2002, May-03, Volume: 442, Issue:1-2

    Topics: Administration, Oral; Animals; Anti-Inflammatory Agents, Non-Steroidal; Celecoxib; Chronic Disease; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Dinoprostone; Dipyrone; Enzyme Inhibitors; Female; Gastric Mucosa; Isoenzymes; Male; Membrane Proteins; Omeprazole; Piroxicam; Prostaglandin-Endoperoxide Synthases; Proton Pump Inhibitors; Pyrazoles; Rats; Rats, Wistar; Stomach; Stomach Ulcer; Sulfonamides; Time Factors; Wound Healing

2002
[Allergic vasculitis following ingestion of celecoxib?].
    Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete, 2002, Volume: 53, Issue:7

    Topics: Administration, Oral; Aged; Celecoxib; Cyclooxygenase Inhibitors; Diagnosis, Differential; Drug Eruptions; Drug Therapy, Combination; Female; Humans; Omeprazole; Proton Pump Inhibitors; Pyrazoles; Sulfonamides; Vasculitis, Leukocytoclastic, Cutaneous

2002
NSAIDs, Helicobacter pylori, and Pandora's Box.
    The New England journal of medicine, 2002, Dec-26, Volume: 347, Issue:26

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Arthritis; Celecoxib; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Diclofenac; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Isoenzymes; Membrane Proteins; Omeprazole; Peptic Ulcer; Peptic Ulcer Hemorrhage; Prostaglandin-Endoperoxide Synthases; Pyrazoles; Sulfonamides

2002
Bioactivation of cyclophosphamide: the role of polymorphic CYP2C enzymes.
    European journal of clinical pharmacology, 2003, Volume: 59, Issue:2

    Topics: Antineoplastic Agents, Alkylating; Aryl Hydrocarbon Hydroxylases; Celecoxib; Cyclophosphamide; Cytochrome P-450 CYP2C19; Cytochrome P-450 CYP2C9; Genotype; Humans; Hydroxylation; In Vitro Techniques; Microsomes; Microsomes, Liver; Mixed Function Oxygenases; Omeprazole; Polymorphism, Genetic; Pyrazoles; Saccharomyces cerevisiae; Sulfonamides

2003
Celecoxib versus diclofenac and omeprazole to prevent recurrent ulcer bleeding.
    The New England journal of medicine, 2003, Jun-12, Volume: 348, Issue:24

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Celecoxib; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Diclofenac; Drug Therapy, Combination; Gastrointestinal Hemorrhage; Humans; Isoenzymes; Membrane Proteins; Omeprazole; Peptic Ulcer Hemorrhage; Prostaglandin-Endoperoxide Synthases; Proton Pump Inhibitors; Pyrazoles; Risk Factors; Secondary Prevention; Sulfonamides

2003
Celecoxib versus diclofenac and omeprazole to prevent recurrent ulcer bleeding.
    The New England journal of medicine, 2003, Jun-12, Volume: 348, Issue:24

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Celecoxib; Contraindications; Cyclooxygenase Inhibitors; Diclofenac; Drug Therapy, Combination; Humans; Kidney Diseases; Omeprazole; Peptic Ulcer Hemorrhage; Pyrazoles; Risk Factors; Secondary Prevention; Sulfonamides

2003
[Selective cox-2 inhibitors. Better tolerance than NSAID plus antacid].
    MMW Fortschritte der Medizin, 2004, Apr-08, Volume: 146, Issue:15

    Topics: Adolescent; Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Celecoxib; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Endoscopy, Digestive System; Gastric Mucosa; Humans; Intestinal Mucosa; Isoenzymes; Membrane Proteins; Middle Aged; Naproxen; Omeprazole; Osteoarthritis; Peptic Ulcer; Prostaglandin-Endoperoxide Synthases; Proton Pump Inhibitors; Pyrazoles; Randomized Controlled Trials as Topic; Sulfonamides

2004
COX-2-specific inhibitor or proton pump inhibitor plus traditional NSAID: is either approach sufficient for patients at highest risk of NSAID-induced ulcers?
    Gastroenterology, 2004, Volume: 127, Issue:4

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Arthritis; Aspirin; Celecoxib; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Diclofenac; Drug Therapy, Combination; Humans; Isoenzymes; Membrane Proteins; Omeprazole; Peptic Ulcer; Prostaglandin-Endoperoxide Synthases; Proton Pump Inhibitors; Pyrazoles; Sulfonamides

2004
Cyclo-oxygenase-2 expression and prostaglandin E2 production in experimental chronic gastric ulcer healing.
    European journal of pharmacology, 2005, Sep-20, Volume: 519, Issue:3

    Topics: Animals; Anti-Ulcer Agents; Blotting, Western; Celecoxib; Chronic Disease; Cyclooxygenase 2; Dinoprostone; Female; Gastric Mucosa; Male; Misoprostol; Omeprazole; Peroxidase; Prostaglandin-Endoperoxide Synthases; Pyrazoles; Rats; Rats, Sprague-Dawley; Stomach Ulcer; Sulfonamides; Wound Healing

2005
Response to Ray and colleagues: the called-for large clinical trial is already ongoing.
    Gastroenterology, 2008, Volume: 134, Issue:1

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Arthritis; Celecoxib; Diclofenac; Humans; Omeprazole; Peptic Ulcer; Pyrazoles; Randomized Controlled Trials as Topic; Sulfonamides

2008
NSAIDs and risk of lower gastrointestinal bleeding.
    Lancet (London, England), 2010, Jul-17, Volume: 376, Issue:9736

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Arthritis, Rheumatoid; Celecoxib; Colonic Diseases; Diclofenac; Gastrointestinal Hemorrhage; Humans; Lower Gastrointestinal Tract; Omeprazole; Osteoarthritis; Peptic Ulcer Hemorrhage; Pyrazoles; Randomized Controlled Trials as Topic; Risk Assessment; Risk Factors; Sulfonamides; Upper Gastrointestinal Tract

2010
"War and Peace" with Barrett's esophagus.
    Digestive diseases and sciences, 2011, Volume: 56, Issue:4

    Topics: Adenocarcinoma; Aged; Anti-Ulcer Agents; Antihypertensive Agents; Aspirin; Barrett Esophagus; Celecoxib; Drug Therapy, Combination; Endoscopy; Esophageal Neoplasms; Fundoplication; Gastroesophageal Reflux; Humans; Hyperlipidemias; Hypertension; Hypolipidemic Agents; Male; Omeprazole; Pyrazoles; Quality of Life; Sulfonamides; Treatment Outcome

2011
Proton pump inhibitors exacerbate NSAID-induced small intestinal injury by inducing dysbiosis.
    Gastroenterology, 2011, Volume: 141, Issue:4

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Actinobacteria; Animals; Anti-Inflammatory Agents, Non-Steroidal; Bifidobacterium; Celecoxib; Colon; Denaturing Gradient Gel Electrophoresis; Disease Models, Animal; Drug Interactions; Gastrointestinal Hemorrhage; Hematocrit; Jejunum; Lansoprazole; Male; Naproxen; Omeprazole; Peptic Ulcer; Probiotics; Proton Pump Inhibitors; Pyrazoles; Rats; Rats, Wistar; Reverse Transcriptase Polymerase Chain Reaction; Sulfonamides; Time Factors

2011
Gastrointestinal-sparing effects of novel NSAIDs in rats with compromised mucosal defence.
    PloS one, 2012, Volume: 7, Issue:4

    Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Arthritis; Aspirin; Celecoxib; Drug Therapy, Combination; Gastric Mucosa; Gastrointestinal Diseases; Gastrointestinal Tract; Hypertension; Male; Naproxen; Nitrates; Obesity; Omeprazole; Pyrazoles; Rats; Rats, Inbred SHR; Rats, Wistar; Rats, Zucker; Sulfonamides

2012
Potent drugs that attenuate anti-Candida albicans activity of fluconazole and their possible mechanisms of action.
    Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2014, Volume: 20, Issue:10

    Topics: Antifungal Agents; ATP-Binding Cassette Transporters; Candida albicans; Candidiasis; Celecoxib; Cyclooxygenase Inhibitors; Diclofenac; Fluconazole; Fungal Proteins; Gene Expression; Ibuprofen; Membrane Transport Proteins; Microbial Sensitivity Tests; Omeprazole; Phenylpropionates; Proton Pump Inhibitors

2014
How to mechanistically explain the CONDOR study data.
    Medical hypotheses, 2015, Volume: 84, Issue:1

    Topics: Arthritis, Rheumatoid; Celecoxib; Cyclooxygenase 2 Inhibitors; Diclofenac; Humans; Intestinal Mucosa; Models, Molecular; Molecular Structure; Omeprazole; Osteoarthritis; Oxidative Phosphorylation; Proton Pump Inhibitors; Pyrazoles; Sulfonamides

2015